Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. (Q52845358)

8 May 2018

title

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. (English)

1 reference

8 May 2018

author name string

Boyer JD

1

1 reference

8 May 2018

Ugen KE

2

1 reference

8 May 2018

Wang B

3

1 reference

8 May 2018

Agadjanyan M

4

1 reference

8 May 2018

Gilbert L

5

1 reference

8 May 2018

Bagarazzi ML

6

1 reference

8 May 2018

Chattergoon M

7

1 reference

8 May 2018

Frost P

8

1 reference

8 May 2018

Javadian A

9

1 reference

8 May 2018

Williams WV

10

1 reference

8 May 2018

Refaeli Y

11

1 reference

8 May 2018

Ciccarelli RB

12

1 reference

8 May 2018

McCallus D

13

1 reference

8 May 2018

Coney L

14

1 reference

8 May 2018

Weiner DB

15

1 reference

8 May 2018

language of work or name

English

0 references

publication date

1 May 1997

1 reference

8 May 2018

published in

Nature Medicine

1 reference

8 May 2018

volume

3

1 reference

8 May 2018

issue

5

1 reference

8 May 2018

page(s)

526-532

1 reference

8 May 2018

https://scigraph.springernature.com/pub.10.1038/nm0597-526

exact match

0 references

cites work

Toward an understanding of the correlates of protective immunity to HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Vertical transmission of human immunodeficiency virus type 1: seroreactivity by maternal antibodies to the carboxy region of the gp41 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gp120.

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Direct transfection of viral and plasmid DNA into the liver or spleen of mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Systemic immunological effects of cytokine genes injected into skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Immunization by direct DNA inoculation induces rejection of tumor cell challenge.

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Genetic immunization is a simple method for eliciting an immune response

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Towards a DNA vaccine against tuberculosis.

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Protection against mycoplasma infection using expression-library immunization

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Improved specificity of in vitro anti-HIV antibody production: implications for diagnosis and timing of transmission in infants born to HIV-seropositive mothers

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

DNA inoculation induces cross clade anti-HIV-1 responses

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Induction of humoral and cellular immune responses to the human immunodeficiency type 1 virus in nonhuman primates by in vivo DNA inoculation

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Gene inoculation generates immune responses against human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

In vivo protective anti-HIV immune responses in non-human primates through DNA immunization.

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice.

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV type 1 env and rev gene products

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Simian immunodeficiency virus DNA vaccine trial in macaques.

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCR.

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-526

7 January 2021

Identifiers

DOI

10.1038/NM0597-526

1 reference

8 May 2018

PubMed ID

9142121

1 reference

8 May 2018